Summary
VECTURA is a biotech business with a twist. Most firms in this sector live a hand-to-mouth existence.
Typically, biotech managements spend their time looking for cash from their shareholders or the bank and there is a strong element of doubt as to whether they will be able to bring their products to market before the money runs out. Vectura, however, is already generating revenues and it has more than [pounds]70 million in the bank.See the full content of this document
Extract
Vectura Looks a Sensible Risk ; Midas
The company has attracted the support of several wellrespected analysts in the City, and the bo...
See the full content of this document
Sponsored links
